Position in MNPR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,423,596
+$4,949,090 QoQ
Shares Held
112,578
+12.7% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 95 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. MNPR ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in MNPR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,423,596 | 112,578 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,474,506 | 99,918 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,465,156 | 99,007 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,938,764 | 84,961 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,467,761 | 96,919 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,767,340 | 48,540 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $849,112 | 38,596 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $94,804 | 14,066 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $43,825 | 60,036 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $28,056 | 41,199 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,007 | 41,199 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,543 | 41,199 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,817 | 41,892 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $58,229 | 41,892 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $99,284 | 41,892 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $59,539 | 39,171 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $90,093 | 39,171 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $99,886 | 39,171 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $125,738 | 39,171 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $190,762 | 39,171 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $169,402 | 28,761 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $163,642 | 26,394 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||